Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Cyanotech (CYAN) Competitors

Cyanotech logo

CYAN vs. HAPP, IMCC, UPXI, AKAN, BON, SMFL, SNDL, TLRY, CRON, and USNA

Should you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), IM Cannabis (IMCC), Upexi (UPXI), Akanda (AKAN), Bon Natural Life (BON), Smart for Life (SMFL), SNDL (SNDL), Tilray (TLRY), Cronos Group (CRON), and USANA Health Sciences (USNA). These companies are all part of the "medicinals & botanicals" industry.

Cyanotech vs.

Cyanotech (NASDAQ:CYAN) and Happiness Development Group (NASDAQ:HAPP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, community ranking, institutional ownership, valuation, dividends and profitability.

Cyanotech has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, Happiness Development Group has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500.

Cyanotech received 101 more outperform votes than Happiness Development Group when rated by MarketBeat users. Likewise, 63.68% of users gave Cyanotech an outperform vote while only 62.79% of users gave Happiness Development Group an outperform vote.

CompanyUnderperformOutperform
CyanotechOutperform Votes
128
63.68%
Underperform Votes
73
36.32%
Happiness Development GroupOutperform Votes
27
62.79%
Underperform Votes
16
37.21%

Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -23.41%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Cyanotech-23.41% -47.42% -21.66%
Happiness Development Group N/A N/A N/A

24.4% of Cyanotech shares are owned by institutional investors. Comparatively, 15.2% of Happiness Development Group shares are owned by institutional investors. 29.1% of Cyanotech shares are owned by insiders. Comparatively, 15.6% of Happiness Development Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Happiness Development Group had 1 more articles in the media than Cyanotech. MarketBeat recorded 1 mentions for Happiness Development Group and 0 mentions for Cyanotech. Happiness Development Group's average media sentiment score of 1.17 beat Cyanotech's score of 0.00 indicating that Happiness Development Group is being referred to more favorably in the news media.

Company Overall Sentiment
Cyanotech Neutral
Happiness Development Group Positive

Cyanotech has higher earnings, but lower revenue than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cyanotech$23.07M0.10-$5.27M-$0.79-0.43
Happiness Development Group$95.59M0.10-$49.19M$0.482.88

Summary

Happiness Development Group beats Cyanotech on 8 of the 14 factors compared between the two stocks.

Get Cyanotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYAN vs. The Competition

MetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$2.43M$1.22B$5.62B$9.13B
Dividend YieldN/AN/A5.36%3.98%
P/E RatioN/A34.4789.4917.56
Price / Sales0.105.701,226.9482.83
Price / CashN/A9.7644.3037.67
Price / Book0.202.045.134.74
Net Income-$5.27M-$53.10M$117.78M$224.51M

Cyanotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYAN
Cyanotech
N/A$0.34
-2.0%
N/A-61.4%$2.43M$23.07M0.0095
HAPP
Happiness Development Group
N/A$1.34
+1.5%
N/A-42.0%$9.32M$95.59M2.79215Positive News
IMCC
IM Cannabis
1.3165 of 5 stars
$2.32
+3.9%
N/A+12.5%$5.17M$36.15M-0.68340Gap Up
UPXI
Upexi
2.9661 of 5 stars
$3.46
-0.6%
$25.00
+622.5%
-84.7%$3.60M$26M0.00130
AKAN
Akanda
N/A$1.58
-5.4%
N/A-94.9%$2.26M$2.16M0.00110Short Interest ↓
News Coverage
BON
Bon Natural Life
N/A$1.49
-10.1%
N/A-78.8%$1.75M$29.52M0.00100News Coverage
Gap Up
High Trading Volume
SMFL
Smart for Life
N/A$0.01
flat
N/A-99.9%$71,000.00$8.23M0.00110Gap Down
SNDL
SNDL
3.5265 of 5 stars
$1.78
-1.1%
$3.25
+82.6%
+22.7%$0.00$673.33M-5.742,516Positive News
TLRY
Tilray
2.7806 of 5 stars
$1.20
+1.7%
$2.70
+125.0%
-46.2%$1.08B$788.94M-4.002,650Gap Up
CRON
Cronos Group
1.5298 of 5 stars
$1.99
+1.0%
$3.00
+50.8%
-8.7%$760.78M$87.24M-15.31450Short Interest ↓
USNA
USANA Health Sciences
3.9135 of 5 stars
$34.02
-0.3%
$38.00
+11.7%
-27.7%$648.33M$921.01M12.021,800News Coverage

Related Companies and Tools


This page (NASDAQ:CYAN) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners